Breaking News
10 minutes ago
Simantini Singh Deo
Onco360 named specialty pharmacy partner for Rigel's VEPPANU, an FDA-approved therapy for ESR1-mutated advanced breast cancer.
Simantini Singh Deo
AscellaHealth appoints Johanna van Nijkerk as VP of Business Development to support AscellaOne's growth and expand modern pharmacy benefit solutions.
Vaibhavi M.

Alamar Biosciences launches its broadest NULISAseq Immune 340 Panel to advance immune profiling and research across cancer, aging and chronic diseases.
Vaibhavi M.

NurExone appoints David Stolick to its Board, bringing extensive finance, M&A and healthcare leadership experience to the exosome therapy company
Vaibhavi M.
